Doctor Discovers Strong Correlation Between Optimal Metabolism and Reduction of Chronic Diseases

NYACK, N.Y. - May 9, 2018 - PRLog -- Dr. Donald T. Levine is excited to announce a new approach to metabolic treatment that dramatically reduces chronic diseases via improved cellular function.

The treatment revolves around achieving a patient's optimal metabolism, which Dr. Levine describes as having the FT3 (free T3) hormone in the upper 20% of the normal range, the TT3/RT3 ratio (total T3/reverse T3) between 10-15, and the FT4 (free T4) greater than or equal to 0.6.

Dr. Levine has used this objective blood test and oral medications to treat 165 patients suffering from a wide range of diseases affecting the immune system, nervous system, digestive system, and skin. Within weeks, those patients reported significant improvements which were recorded as "average percent improvements" (API). Improvements were seen in a wide range of areas, including the immunology, neurology, dermatology, and gastroenterology. For further analysis, view Dr. Levine's published case study entitled, The Definition of Optimal Metabolism and its Association with Large Reductions in Chronic Diseases (http://www.oatext.com/pdf/TiM-18-122.pdf).

Average Percent Improvement in Patient-Reported Symptoms

• Immune System - 63%
• Neurology - 80%
• Dermatology - 70%
• Gastroenterology/Constipation - 74%

"Optimal metabolism is a brand new, extremely effective treatment," Dr. Levine said. "Most physicians are not aware of it, and once I realized its obvious benefits, I wanted to share it with my colleagues and patients."

Dr. Levine believes the current standard places too much emphasis on the thyroid-stimulating hormone (TSH), while minimizing the importance of FT3, FT4, and the TT3/RT3 ratio.

"The feedback from my patients has been tremendous. This treatment has helped so many people with a variety of diseases. I am beyond excited to share my findings and continue treating patients who just want solutions," Levine said.